Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Excitatory glutamatergic synaptic transmission in the spinal dorsal horn is the primary physiological mechanism for the relay of nociceptive signals from the periphery to the central nervous system (StatPearls, 2023). This process involves the release of glutamate from primary afferent terminals and its subsequent activation of postsynaptic ionotropic receptors, including AMPA, NMDA, and kainate receptors, as well as metabotropic glutamate receptors (mGluRs) (PubMed, PMID: 29029618). Under conditions of chronic injury or inflammation, this pathway undergoes plastic changes known as central sensitization, which leads to an exaggerated response to painful stimuli (hyperalgesia) and pain from non-painful stimuli (allodynia) (Nature Reviews Neuroscience, 2011). Pharmacological targeting of this transmission involves the use of NMDA receptor antagonists, such as ketamine, or drugs that modulate presynaptic glutamate release, such as gabapentinoids (PubChem). While these interventions are effective for managing chronic pain, they are often limited by safety concerns such as sedation, ataxia, and cognitive impairment due to the ubiquitous role of glutamate in the central nervous system (NIH, 2022).
Modulation of excitatory signaling through the antagonism of postsynaptic glutamate receptors (NMDA, AMPA) or the inhibition of presynaptic glutamate release via voltage-gated calcium channel modulation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Excitatory glutamatergic synaptic transmission in spinal dorsal horn.